Characteristic | All patients n = 849 | AKI n = 497 | No AKI n = 352 | p-value |
---|---|---|---|---|
Demographics | ||||
 Mean age, yearsa (SD) | 42.5 (16.8) | 43.7 (16.8) | 40.9 (16.6) | 0.017 |
 Male gendera % | 58.9 | 61.2 | 55.7 | 0.110 |
Racea % | ||||
 Black African | 58.0 | 60.5 | 54.3 | 0.067 |
 Mixed Ancestry | 27.4 | 26.0 | 29.6 | 0.248 |
 BCaucasian | 13.8 | 12.7 | 15.3 | 0.267 |
 Other | 0.8 | 0.8 | 0.8 | 0.827 |
Co-morbidities | ||||
 Diabetesa % | 13.2 | 16.1 | 9.1 | 0.003 |
 Mean HbA1c % (SD) | 9.9 (3.2) | 10.3 (3.1) | 9.1 (3.3) | 0.142 |
 Hypertensiona % | 31.6 | 32.2 | 30.7 | 0.641 |
 Ischaemic heart disease % | 4.2 | 4.6 | 3.7 | 0.506 |
 Active Tuberculosis % | 6.1 | 6.6 | 5.4 | 0.457 |
 Chronic kidney diseasea % | 7.7 | 6.4 | 9.4 | 0.113 |
 Mean CKD eGFR (SD) | 32 (19) | 40 (16) | 21 (1) | < 0.001 |
 Epilepsy % | 4.8 | 5.0 | 4.6 | 0.746 |
 Malignancya % | 3.3 | 3.6 | 2.8 | 0.530 |
HIV | ||||
Known status, n = 472 (56.1%) | ||||
 Positive, n (%) | 155 (32.6) | 105 (35.1) | 50 (28.3) | 0.010 |
 Negative, n (%) | 321 (67.4) | 194 (64.9) | 127 (71.8) | 0.382 |
In HIV positive cohort: | ||||
 Median CD4 count, cells/μL (IQR) | 318(156–493) | 205 (119–391) | 404 (308–513) | 0.025 |
 Median viral load, log (IQR) | 2.0 (1.98–4.04) | 2.0 (1.88-3.62) | 2.5 (2.00–4.64) | 0.234 |
 Receiving HAARTa % | 11.9 | 14.5 | 8.2 | 0.006 |
Severity of illness | ||||
 Emergency admissions % | 87.0 | 92.8 | 79.0 | < 0.001 |
 Mean SAPS 3 scorea (SD) | 48.1 | 54.0 | 39.7 | < 0.001 |
 Median highest SOFA scorea (IQR) | 4 (1–6) | 6 (3–9) | 2 (1–4) | < 0.001 |
 Sepsis and septic shocka % | 30.2 | 43.1 | 11.9 | < 0.001 |
 Ventilateda % | 53.7 | 64.8 | 38.2 | < 0.001 |
 median ventilator days (IQR) | 3 (1–7) | 3 (1–8) | 2 (1–4) | < 0.001 |
 Required vasopressorsa % | 25.0 | 38.8 | 5.4 | < 0.001 |
 ARDSa % | 4.4 | 6.8 | 0.9 | < 0.001 |
 Median ICU days (IQR) | 3 (1–6) | 4 (2–8) | 2 (1–4) | < 0.001 |
 ICU length of stay > 7 daysa % | 24.7 | 33.2 | 12.8 | < 0.001 |
 Deceased in ICU % | 13.0 | 20.5 | 2.3 | < 0.001 |